Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiongshao Analgesic Granules
- Development stage
- Unknown
- Lead developer
- Guangdong Kaizhong Biotechnology
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xiongshao Analgesic Granules is a Traditional Chinese Medicine (TCM) granule formulation developed by Guangdong Kaizhong Biotechnology for the treatment of migraine. It is specifically indicated for patients diagnosed with migraine (with or without aura) who exhibit the "wind-phlegm-blood stasis" pattern according to TCM principles. The formulation likely contains extracts from *Ligusticum chuanxiong* (Chuanxiong) and *Paeonia lactiflora* (Baishao), which are traditionally used in Chinese medicine to promote blood circulation, dispel wind, and alleviate pain. It is currently undergoing Phase 2 clinical evaluation in China to assess its efficacy and safety.
- Other names
- Xiongshao Zhitong GranulesXiongshao Zhitong Keli芎芍止痛颗粒
02
Targets
TRPV1 (Transient receptor potential cation channel subfamily V member 1)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)
Beyond the preview
Go deeper on Xiongshao Analgesic Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiongshao Analgesic Granules.